Michael Neely

Процитировано

	Все	Начиная с 2018 г.
Статистика цитирования	7959	4858
h-индекс	43	32
i10-индекс	123	101

1300

650

325

975

20032004200520062007200820092010201120122013201420152016201720182019202020212022202330 31 35 39 42 62 53 103 157 191 288 353 444 531 586 650 691 851 1129 1276 245

Общий доступ

Просмотреть все

98 статей

7 статей

доступно

недоступно

На основе финансирования

Соавторы

William HopeUniversity of LiverpoolПодтвержден адрес электронной почты в домене liverpool.ac.uk
Jason RobertsUniversity of QueenslandПодтвержден адрес электронной почты в домене uq.edu.au
Van Den Anker JProfessor of Pediatrics, George Washington UniversityПодтвержден адрес электронной почты в домене cnmc.org
Marc H. ScheetzProfessor of Pharmacy and Pharmacology, Midwestern University, Colleges of Pharmacy and GraduateПодтвержден адрес электронной почты в домене midwestern.edu
Charles PeloquinProfessor of Pharmacy, University of FloridaПодтвержден адрес электронной почты в домене cop.ufl.edu
Tim FeltonSenior Lecturer, University of ManchesterПодтвержден адрес электронной почты в домене manchester.ac.uk
Andrea KovacsUniversity of Southern CaliforniaПодтвержден адрес электронной почты в домене usc.edu
Stan LouieUniversity of Southern CaliforniaПодтвержден адрес электронной почты в домене usc.edu
Nathaniel J. RhodesMidwestern UniversityПодтвержден адрес электронной почты в домене midwestern.edu
Jean-Baptiste WoillardCHU Limoges, Department of Pharmacology and Toxicology, Limoges, France; University of LimogesПодтвержден адрес электронной почты в домене unilim.fr
Mohd-Hafiz Abdul-AzizUniversity of QueenslandПодтвержден адрес электронной почты в домене uqconnect.edu.au
BleyzacПодтвержден адрес электронной почты в домене chu-lyon.fr
Jay BartroffProfessor of Statistics and Data Sciences, University of Texas at AustinПодтвержден адрес электронной почты в домене austin.utexas.edu
Tatiana V. TatarinovaFletcher Jones Endowed Chair in Computational Biology, University of LaVerneПодтвержден адрес электронной почты в домене laverne.edu
Ursula TheuretzbacherCenter for Anti-Infective Agents, ViennaПодтвержден адрес электронной почты в домене aon.at
Catherijne A.J. KnibbeProfessor of Individualized Drug Treatment, Leiden UniversityПодтвержден адрес электронной почты в домене antoniusziekenhuis.nl
Anders ÅsbergUniversity of OsloПодтвержден адрес электронной почты в домене farmasi.uio.no
Mahmoud GhannoumCase Western Reserve UniversityПодтвержден адрес электронной почты в домене case.edu

Michael Neely

University of Southern California

Подтвержден адрес электронной почты в домене usc.edu - Главная страница

Pediatric Infectious Diseases Pharmacometrics Personalized Medicine


Название По числу цитат По году По названию	Процитировано Процитировано	Год
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ... The Lancet infectious diseases 14 (6), 498-509, 2014	765	2014
Accurate detection of outliers and subpopulations with Pmetrics, a non-parametric and parametric pharmacometric modeling and simulation package for R M Neely, M van Guilder, W Yamada, A Schumitzky, R Jelliffe Therapeutic drug monitoring 34 (4), 467, 2012	460	2012
More codeine fatalities after tonsillectomy in North American children LE Kelly, M Rieder, J van den Anker, B Malkin, C Ross, MN Neely, ... Pediatrics 129 (5), e1343-e1347, 2012	414	2012
Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper_# MH Abdul-Aziz, JWC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ... Intensive care medicine 46, 1127-1153, 2020	366	2020
Are vancomycin trough concentrations adequate for optimal dosing? MN Neely, G Youn, B Jones, RW Jelliffe, GL Drusano, KA Rodvold, ... Antimicrobial agents and chemotherapy 58 (1), 309-316, 2014	347	2014
Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing MN Neely, L Kato, G Youn, L Kraler, D Bayard, M van Guilder, ... Antimicrobial agents and chemotherapy 62 (2), e02042-17, 2018	271	2018
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents TJ Walsh, PC Adamson, NL Seibel, PM Flynn, MN Neely, C Schwartz, ... Antimicrobial agents and chemotherapy 49 (11), 4536-4545, 2005	264	2005
Voriconazole pharmacokinetics and pharmacodynamics in children M Neely, T Rushing, A Kovacs, R Jelliffe, J Hoffman Clinical infectious diseases 50 (1), 27-36, 2010	242	2010
Innovative approaches to optimizing the delivery of vancomycin in individual patients MP Pai, M Neely, KA Rodvold, TP Lodise Advanced drug delivery reviews 77, 50-57, 2014	233	2014
Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients DF Florescu, SA Pergam, MN Neely, F Qiu, C Johnston, SS Way, J Sande, ... Biology of Blood and Marrow Transplantation 18 (5), 731-738, 2012	175	2012
Why has model‐informed precision dosing not yet become common clinical reality? Lessons from the past and a roadmap for the future AS Darwich, K Ogungbenro, AA Vinks, JR Powell, JL Reny, N Marsousi, ... Clinical Pharmacology & Therapeutics 101 (5), 646-656, 2017	163	2017
International Society of Anti-Infective Pharmacology and the Pharmacokinetics and Pharmacodynamics Study Group of the European Society of Clinical Microbiology and Infectious … JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ... Lancet Infect Dis 14 (6), 498-509, 2014	149	2014
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected … PENPACT-1 (PENTA 9/PACTG 390) Study Team The Lancet infectious diseases 11 (4), 273-283, 2011	124	2011
Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy MN Neely, L Benning, J Xu, HD Strickler, RM Greenblatt, H Minkoff, ... Journal of acquired immune deficiency syndromes (1999) 44 (1), 38, 2007	119	2007
Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients LS Eiland, TM English, EH Eiland III Annals of Pharmacotherapy 45 (5), 582-589, 2011	117	2011
Two general methods for population pharmacokinetic modeling: non-parametric adaptive grid and non-parametric Bayesian T Tatarinova, M Neely, J Bartroff, M van Guilder, W Yamada, D Bayard, ... Journal of pharmacokinetics and pharmacodynamics 40, 189-199, 2013	105	2013
The exciting future of antifungal therapy MN Neely, MA Ghannoum European Journal of Clinical Microbiology and Infectious Diseases 19, 897-914, 2000	101	2000
Improved tacrolimus target concentration achievement using computerized dosing in renal transplant recipients–a prospective, randomized study E Størset, A Åsberg, M Skauby, M Neely, S Bergan, S Bremer, K Midtvedt Transplantation 99 (10), 2158, 2015	97	2015
Adipocytes sequester and metabolize the chemotherapeutic daunorubicin X Sheng, JH Parmentier, J Tucci, H Pei, O Cortez-Toledo, ... Molecular Cancer Research 15 (12), 1704-1713, 2017	85	2017
Pharmacokinetics and safety of caspofungin in older infants and toddlers M Neely, HS Jafri, N Seibel, K Knapp, PC Adamson, SK Bradshaw, ... Antimicrobial agents and chemotherapy 53 (4), 1450-1456, 2009	85	2009

В данный момент система не может выполнить эту операцию. Повторите попытку позднее.

Статьи 1–20

Ссылок за год

Повторяющиеся цитирования

Объединенные цитирования

СоавторыСоавторы

Подписаться

Процитировано

Соавторы